{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "10"
        },
        "variant_string_id": "DJ-1 L10P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "A variety of mutations in the gene encoding DJ-1 protein are causal of autosomal recessive early-onset parkinsonism. The current study suggests that L10P DJ-1 mutations may be causative of disease by mechanisms involving altered protein stability and protein folding.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly links DJ-1 mutations, including L10P, to early-onset parkinsonism and describes a loss-of-function mechanism involving reduced protein stability and altered folding, which are relevant to the disease pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The biochemical properties of the novel pathogenic DJ-1 mutant L10P are explored through assays assessing protein stability (pulse-chase), dimerization (co-immunoprecipitation and crosslinking), solubility (biochemical fractionation), subcellular localization (immunofluorescence), and protective function (cell viability under proteasome stress).",
          "judgment": "Yes",
          "reasoning": "The general classes of assays used (e.g., protein stability, dimerization, solubility, and cell viability assays) are relevant and widely accepted in the field for modeling the loss-of-function mechanisms associated with DJ-1 mutations in parkinsonism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Wild-type (WT) DJ-1 was used as a normal/negative control, and L166P DJ-1 (a known pathogenic variant) as an abnormal/positive control in assays. Experiments such as pulse-chase, steady-state protein analysis, and cell viability were performed in triplicates or more (e.g., n=6 for viability assays).",
          "judgment": "Yes",
          "reasoning": "The paper includes both normal (WT DJ-1) and abnormal (L166P DJ-1) controls in the assays for L10P. Multiple replicates are explicitly mentioned for key experiments (e.g., triplicates in pulse-chase and n=6 in viability studies).",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "L166P DJ-1, a known pathogenic variant, was used as a control in comparison to L10P DJ-1 across multiple assays including protein stability, dimerization, and solubility.",
          "judgment": "Yes",
          "reasoning": "The use of L166P DJ-1 as a known pathogenic variant control satisfies the requirement for variant controls in the assays for L10P.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "Statistical analyses were performed using GraphPad Prism 5.0. Two-way ANOVA and Bonferroni's post hoc tests were used to assess significance in protein turnover (p=0.0015), stability under proteasome inhibition (p=0.0061), and cell viability (p<.0001 for inclusion formation).",
          "judgment": "Yes",
          "reasoning": "The paper provides robust statistical analyses with p-values for key functional assays, which can be used to infer the strength of evidence for pathogenicity, although direct OddsPath calculation is not provided.",
          "next_step_or_outcome": "Proceed to Step 4c"
        },
        {
          "step_name": "Step 4c: Correlate OddsPath",
          "extracted_paper_info": "Significant differences were found in protein stability (p<.05 to p<.01 at various time points), solubility, inclusion formation (p<.001), and cell viability (reduced viability with L10P under stress, p-values significant via ANOVA). No direct OddsPath is calculated, but the effect sizes are consistently large compared to WT.",
          "judgment": "Moderate",
          "reasoning": "Without a direct OddsPath value, the strength is inferred from the consistent and statistically significant functional deficits (stability, solubility, toxicity) of L10P compared to WT DJ-1. The effect size and significance suggest a moderate level of evidence for pathogenicity (OddsPath equivalent likely >4.3 but not definitively >18.7).",
          "next_step_or_outcome": "Assign PS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The functional evidence for L10P DJ-1 supports a pathogenic role with moderate strength (PS3_moderate) due to significant reductions in protein stability, impaired homodimerization, reduced solubility, inclusion formation, and toxicity under proteasome stress, all statistically validated compared to WT DJ-1."
    },
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "P",
          "alt": "DEL",
          "position": "158"
        },
        "variant_string_id": "DJ-1 P158DEL"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "A variety of mutations in the gene encoding DJ-1 protein are causal of autosomal recessive early-onset parkinsonism. The current study suggests that P158DEL DJ-1 mutations may be causative of disease by mechanisms involving altered protein stability and protein folding.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly links DJ-1 mutations, including P158DEL, to early-onset parkinsonism and describes a loss-of-function mechanism involving reduced protein stability and altered folding, relevant to disease pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The biochemical properties of the novel pathogenic DJ-1 mutant P158DEL are explored through assays assessing protein stability (pulse-chase), dimerization (co-immunoprecipitation and crosslinking), solubility (biochemical fractionation), subcellular localization (immunofluorescence), and protective function (attempted cell viability studies).",
          "judgment": "Yes",
          "reasoning": "The general classes of assays used (e.g., protein stability, dimerization, solubility assays) are relevant and accepted in the field for modeling loss-of-function mechanisms associated with DJ-1 mutations in parkinsonism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Wild-type (WT) DJ-1 was used as a normal/negative control, and L166P DJ-1 (a known pathogenic variant) as an abnormal/positive control in assays. Experiments such as pulse-chase and steady-state protein analysis were performed in triplicates or more (e.g., n=5 for stability under MG-132).",
          "judgment": "Yes",
          "reasoning": "The paper includes both normal (WT DJ-1) and abnormal (L166P DJ-1) controls in the assays for P158DEL. Multiple replicates are explicitly mentioned for key experiments (e.g., triplicates in pulse-chase and n=5 in stability studies).",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "L166P DJ-1, a known pathogenic variant, was used as a control in comparison to P158DEL DJ-1 across multiple assays including protein stability, dimerization, and solubility.",
          "judgment": "Yes",
          "reasoning": "The use of L166P DJ-1 as a known pathogenic variant control satisfies the requirement for variant controls in the assays for P158DEL.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "Statistical analyses were performed using GraphPad Prism 5.0. Two-way ANOVA and Bonferroni's post hoc tests were used to assess significance in protein turnover (p=0.0015), stability under proteasome inhibition (p=0.0061), and inclusion formation (p<.0001).",
          "judgment": "Yes",
          "reasoning": "The paper provides robust statistical analyses with p-values for key functional assays, which can be used to infer the strength of evidence for pathogenicity, although direct OddsPath calculation is not provided.",
          "next_step_or_outcome": "Proceed to Step 4c"
        },
        {
          "step_name": "Step 4c: Correlate OddsPath",
          "extracted_paper_info": "Significant differences were found in protein stability (p<.001 to p<.01 at various time points), solubility, and inclusion formation (p<.001) for P158DEL compared to WT. No direct OddsPath is calculated, but the effect sizes are consistently large compared to WT. Cell viability data is absent as stable lines could not be established.",
          "judgment": "Moderate",
          "reasoning": "Without a direct OddsPath value, the strength is inferred from the consistent and statistically significant functional deficits (stability, solubility, inclusion formation) of P158DEL compared to WT DJ-1. The effect size and significance suggest a moderate level of evidence for pathogenicity (OddsPath equivalent likely >4.3 but not definitively >18.7).",
          "next_step_or_outcome": "Assign PS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The functional evidence for P158DEL DJ-1 supports a pathogenic role with moderate strength (PS3_moderate) due to significant reductions in protein stability, impaired homodimerization, reduced solubility, and inclusion formation, all statistically validated compared to WT DJ-1, despite the lack of cell viability data."
    },
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "166"
        },
        "variant_string_id": "DJ-1 L166P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "A variety of mutations in the gene encoding DJ-1 protein are causal of autosomal recessive early-onset parkinsonism. The current study suggests that L166P DJ-1 mutations may be causative of disease by mechanisms involving altered protein stability and protein folding.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly links DJ-1 mutations, including L166P, to early-onset parkinsonism and describes a loss-of-function mechanism involving reduced protein stability and altered folding, relevant to disease pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The biochemical properties of the known pathogenic DJ-1 mutant L166P are explored through assays assessing protein stability (pulse-chase), dimerization (co-immunoprecipitation and crosslinking), solubility (biochemical fractionation), subcellular localization (immunofluorescence), and protective function (cell viability under proteasome stress in prior studies).",
          "judgment": "Yes",
          "reasoning": "The general classes of assays used (e.g., protein stability, dimerization, solubility assays) are relevant and accepted in the field for modeling loss-of-function mechanisms associated with DJ-1 mutations in parkinsonism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Wild-type (WT) DJ-1 was used as a normal/negative control, and L166P DJ-1 itself is a known pathogenic variant used as an abnormal/positive control in assays. Experiments such as pulse-chase and steady-state protein analysis were performed in triplicates or more (e.g., n=5 for stability under MG-132).",
          "judgment": "Yes",
          "reasoning": "The paper includes both normal (WT DJ-1) and abnormal (L166P DJ-1) controls in the assays. Multiple replicates are explicitly mentioned for key experiments (e.g., triplicates in pulse-chase and n=5 in stability studies).",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "L166P DJ-1 is itself a known pathogenic variant and was used as a control in comparison to WT and other mutants across multiple assays including protein stability, dimerization, and solubility.",
          "judgment": "Yes",
          "reasoning": "The use of L166P DJ-1 as a known pathogenic variant control satisfies the requirement for variant controls in the assays.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "Statistical analyses were performed using GraphPad Prism 5.0. Two-way ANOVA and Bonferroni's post hoc tests were used to assess significance in protein turnover (p=0.0015), stability under proteasome inhibition (p=0.0061), and inclusion formation (p<.0001).",
          "judgment": "Yes",
          "reasoning": "The paper provides robust statistical analyses with p-values for key functional assays, which can be used to infer the strength of evidence for pathogenicity, although direct OddsPath calculation is not provided.",
          "next_step_or_outcome": "Proceed to Step 4c"
        },
        {
          "step_name": "Step 4c: Correlate OddsPath",
          "extracted_paper_info": "Significant differences were found in protein stability (p<.001 at multiple time points), solubility, inclusion formation (p<.001), and prior studies indicate toxicity under proteasome stress for L166P compared to WT. No direct OddsPath is calculated, but the effect sizes are consistently large compared to WT.",
          "judgment": "Moderate",
          "reasoning": "Without a direct OddsPath value, the strength is inferred from the consistent and statistically significant functional deficits (stability, solubility, inclusion formation, known toxicity) of L166P compared to WT DJ-1. The effect size and significance suggest a moderate level of evidence for pathogenicity (OddsPath equivalent likely >4.3 but not definitively >18.7).",
          "next_step_or_outcome": "Assign PS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The functional evidence for L166P DJ-1 supports a pathogenic role with moderate strength (PS3_moderate) due to significant reductions in protein stability, impaired dimerization, reduced solubility, inclusion formation, and known toxicity under proteasome stress, all statistically validated compared to WT DJ-1."
    }
  ]
}